Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
Clinical trial NCT03641573 · COMPLETED
Trial details
- NCT number
- NCT03641573
- Sponsor
- Asana BioSciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2018-10-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.